[ad_1] Alector won $ 133 million through a fifth round of venture capital financing, with the intention of getting at least three of its immunomodulatory drugs into clinical trials against neurodegenerative diseases. …
Read More »Alector Raises $ 133 Million in VC's 5th Round to Push Neuroimmunological Drugs Into Alzheimer's Trials
